Risk factors

Revenue depends heavily on rare earth prices, concentrated customer relationships, and execution of complex capital projects like Stage II and Independence.

Middlesex Water Company's risks are dominated by heavy reliance on regulated rates, environmental compliance, and geographic concentration in New Jersey and Delaware. Water supply availability, physical security threats, and municipal contract cost overruns also pose material threats.

Initial filing with no prior year comparison. Risk factors concentrate heavily on macroeconomic conditions, project execution, and regulatory compliance. Key exposures include fixed-price contracts, union workforces, and environmental or climate regulations.

NBT Bancorp's risk profile is heavily weighted toward regional economic concentration, credit risk in commercial lending, and execution risks tied to the pending merger with Evans.

NextDecade faces heavy indebtedness and cash flow risks tied to the construction phase of Phase 1 of the Rio Grande LNG Facility. The company depends heavily on third-party contractors, suppliers at the Agua Dulce Hub, and commercial counterparties. Future growth relies on successfully developing CCS projects, obtaining additional financing, and maintaining regulatory approvals and permits.

Federal SNF staffing mandates could raise labor costs, reduce patient census, and pressure profitability.

Rental operations depend on managing a $122.8 million fleet across the United States and United Kingdom.

Natural Resource Partners LP relies heavily on coal royalties from key customers Alpha and Foresight, alongside soda ash distributions from Sisecam Wyoming.

Revenue depends heavily on unpredictable patent litigation outcomes and historical concentration in the Remote Power Patent. The company faces significant reliance on CEO Corey M. Horowitz and substantial capital exposure in biotech startup ILiAD. Patent enforcement costs and risks are amplified by adverse legislative, judicial, and artificial intelligence developments.

enVVeno Medical faces extreme concentration risk relying on only two domestic suppliers for porcine tissue. The company relies entirely on its Irvine facility for manufacturing product candidates. Regulatory hurdles and capital raising needs dominate the risk profile.

Heavy reliance on regulated utility rate-making, customer growth, and environmental safety compliance.